ES2071617T3 - Sistema de suministro de medicamentos en bolsa. - Google Patents

Sistema de suministro de medicamentos en bolsa.

Info

Publication number
ES2071617T3
ES2071617T3 ES88307563T ES88307563T ES2071617T3 ES 2071617 T3 ES2071617 T3 ES 2071617T3 ES 88307563 T ES88307563 T ES 88307563T ES 88307563 T ES88307563 T ES 88307563T ES 2071617 T3 ES2071617 T3 ES 2071617T3
Authority
ES
Spain
Prior art keywords
medicines
bags
supply
solid
carrier
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
ES88307563T
Other languages
English (en)
Inventor
George N C O K V Ph Paradissis
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
K V PHARMACEUTICALS Inc
Original Assignee
K V PHARMACEUTICALS Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by K V PHARMACEUTICALS Inc filed Critical K V PHARMACEUTICALS Inc
Application granted granted Critical
Publication of ES2071617T3 publication Critical patent/ES2071617T3/es
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0087—Galenical forms not covered by A61K9/02 - A61K9/7023
    • A61K9/0095—Drinks; Beverages; Syrups; Compositions for reconstitution thereof, e.g. powders or tablets to be dispersed in a glass of water; Veterinary drenches
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00—Medicinal preparations containing inorganic active ingredients
    • A61K33/14—Alkali metal chlorides; Alkaline earth metal chlorides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A61K9/1605—Excipients; Inactive ingredients
    • A61K9/1617—Organic compounds, e.g. phospholipids, fats
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
    • A61K9/5005—Wall or coating material
    • A61K9/501—Inorganic compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
    • A61K9/5005—Wall or coating material
    • A61K9/5015—Organic compounds, e.g. fats, sugars

Abstract

UN SISTEMA DE DESCARGA DE UNA DROGA EN EL CUAL UN SOLIDO ENMASCARADO CON UN SABOR ES SUSPENDIDO EN UN LIQUIDO PORTADOR. EL SOLIDO HA SIDO TRANSFORMADO EN HIDROFILO Y SU DENSIDAD SE APROXIMA A LA DEL LIQUIDO PORTADOR.
ES88307563T 1985-09-11 1988-08-15 Sistema de suministro de medicamentos en bolsa. Expired - Lifetime ES2071617T3 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US06/775,419 US4764375A (en) 1985-09-11 1985-09-11 Sachet drug delivery system

Publications (1)

Publication Number Publication Date
ES2071617T3 true ES2071617T3 (es) 1995-07-01

Family

ID=25104359

Family Applications (1)

Application Number Title Priority Date Filing Date
ES88307563T Expired - Lifetime ES2071617T3 (es) 1985-09-11 1988-08-15 Sistema de suministro de medicamentos en bolsa.

Country Status (5)

Country Link
US (1) US4764375A (es)
EP (1) EP0354973B1 (es)
AT (1) ATE119768T1 (es)
DE (1) DE3853361T2 (es)
ES (1) ES2071617T3 (es)

Families Citing this family (26)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5095035A (en) * 1981-07-31 1992-03-10 Eby Iii George A Flavor stable zinc acetate compositions for oral absorption
US5270056A (en) * 1985-10-25 1993-12-14 Aktiebolaget Hassle Particle having a dyed coke indicator and a pharmaceutical coating for parenteral administration of the pharmaceutical
NL193682C (nl) * 1987-05-14 2000-07-04 Glaxo Group Ltd Beklede cefuroximaxetilsamenstelling.
US4871718A (en) * 1987-12-29 1989-10-03 Raymond A. Roncari Composition of matter for increasing intracellular ATP levels and physical performance levels and for increasing the rate of wound repair
DE4200821A1 (de) * 1992-01-15 1993-07-22 Bayer Ag Geschmacksmaskierte pharmazeutische mittel
EP0663818A4 (en) * 1992-09-03 1996-04-24 Ibah Inc TASTE-COVERING PHARMACEUTICAL SUMMARY AND METHOD FOR PRODUCING THE SAME.
US6214386B1 (en) 1995-11-22 2001-04-10 Recordati, S.A. Prompt-release oral pharmaceutical compositions for extemporaneous suspensions
IT1276160B1 (it) * 1995-11-22 1997-10-27 Recordati Chem Pharm Composizioni farmaceutiche orali a pronto rilascio per sospensioni estemporanee
US20030091629A1 (en) 1998-03-27 2003-05-15 Cima Labs Inc. Sublingual buccal effervescent
US6974590B2 (en) 1998-03-27 2005-12-13 Cima Labs Inc. Sublingual buccal effervescent
US8119159B2 (en) * 1999-02-22 2012-02-21 Merrion Research Iii Limited Solid oral dosage form containing an enhancer
US7658938B2 (en) 1999-02-22 2010-02-09 Merrion Reasearch III Limited Solid oral dosage form containing an enhancer
US20070148228A1 (en) * 1999-02-22 2007-06-28 Merrion Research I Limited Solid oral dosage form containing an enhancer
WO2001091730A1 (en) * 2000-05-31 2001-12-06 Drugtech Corporation Mineral supplement
US20030068356A1 (en) 2001-07-10 2003-04-10 Pather S. Indiran Sequential drug delivery systems
US7858121B2 (en) 2003-12-31 2010-12-28 Cima Labs, Inc. Effervescent oral fentanyl dosage form and methods of administering fentanyl
DE602004031771D1 (de) 2003-12-31 2011-04-21 Cima Labs Inc Brauseformen von opiaten zur oralen anwendung und verfahren zur verabreichung von oxycodon
PL1708686T3 (pl) 2003-12-31 2011-08-31 Cima Labs Inc Doustna forma dawkowania fentanylu w postaci musującej o charakterze liniowym oraz sposoby jego podawania
BRPI0710503A2 (pt) * 2006-04-07 2011-08-16 Merrion Res Iii Ltd uso de uma composição farmacêutica, composição farmacêutica, e, forma de dosagem oral
EP2040731A4 (en) * 2006-06-09 2010-05-19 Merrion Res Iii Ltd SOLID DOSAGE FORM FOR ORAL ADMINISTRATION CONTAINING AN ACTIVATOR
CA2723541A1 (en) * 2008-05-07 2009-11-12 Merrion Research Iii Limited Compositions of peptides and processes of preparation thereof
CA2751854A1 (en) * 2009-02-25 2010-09-02 Merrion Research Iii Limited Composition and drug delivery of bisphosphonates
US20110182985A1 (en) * 2010-01-28 2011-07-28 Coughlan David C Solid Pharmaceutical Composition with Enhancers and Methods of Preparing thereof
WO2011120033A1 (en) * 2010-03-26 2011-09-29 Merrion Research Iii Limited Pharmaceutical compositions of selective factor xa inhibitors for oral administration
BR112013017169A2 (pt) 2011-01-07 2016-10-04 Merrion Res Iii Ltd composições farmacêuticas de ferro para administração oral
EP3250191B1 (en) 2015-01-29 2024-01-17 Novo Nordisk A/S Tablets comprising glp-1 agonist and enteric coating

Family Cites Families (21)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
BE555932A (es) *
US2276531A (en) * 1938-06-18 1942-03-17 Nat Oil Prod Co Water-dispersible vitamin composition
US2487336A (en) * 1946-02-25 1949-11-08 William E Hinds Penicillin product
US2902407A (en) * 1955-06-14 1959-09-01 Commercial Solvents Corp Wax-coated penicillin product
US3037911A (en) * 1959-09-04 1962-06-05 Merck & Co Inc Chewable, palatable, vitamin b preparations
US3080292A (en) * 1960-07-12 1963-03-05 Hoffmann La Roche Stable pleasant-tasting vitamin b containing beadlets
US3080293A (en) * 1960-08-02 1963-03-05 Hoffmann La Roche Process of making pleasant-tasting niacinamide beadlets
US3138524A (en) * 1962-06-06 1964-06-23 Hoffmann La Roche Pharmaceutical suspensions
US3279994A (en) * 1963-02-19 1966-10-18 Hoffmann La Roche Riboflavin beadlet composition
US3737551A (en) * 1969-08-20 1973-06-05 Vanderbilt Co R T Wettable and dispersible powders
US3780170A (en) * 1972-07-03 1973-12-18 Warner Lambert Co Tasteless methenamine mandelate
JPS53148535A (en) * 1977-05-26 1978-12-25 Morishita Shigeo Protective agent for cancer
US4166800A (en) * 1977-08-25 1979-09-04 Sandoz, Inc. Processes for preparation of microspheres
US4384975A (en) * 1980-06-13 1983-05-24 Sandoz, Inc. Process for preparation of microspheres
US4259315A (en) * 1980-06-13 1981-03-31 A. H. Robins Company, Inc. Controlled release potassium dosage form
ZA822995B (en) * 1981-05-21 1983-12-28 Wyeth John & Brother Ltd Slow release pharmaceutical composition
SE8103843L (sv) * 1981-06-18 1982-12-19 Astra Laekemedel Ab Farmaceutisk mixtur
US4479911A (en) * 1982-01-28 1984-10-30 Sandoz, Inc. Process for preparation of microspheres and modification of release rate of core material
FR2549371B1 (fr) * 1983-07-20 1985-09-13 Sanofi Sa Nouvelle composition pharmaceutique contenant de l'acide valproique ou un de ses sels
EP0179583A1 (en) * 1984-10-04 1986-04-30 Merck & Co. Inc. A system for enhancing the water dissolution rate and solubility of poorly soluble drugs
US4786508A (en) * 1986-05-30 1988-11-22 Warner-Lambert Company Coated dosage forms

Also Published As

Publication number Publication date
EP0354973B1 (en) 1995-03-15
ATE119768T1 (de) 1995-04-15
US4764375A (en) 1988-08-16
DE3853361T2 (de) 1995-08-03
EP0354973A1 (en) 1990-02-21
DE3853361D1 (de) 1995-04-20

Similar Documents

Publication Publication Date Title
ES2071617T3 (es) Sistema de suministro de medicamentos en bolsa.
ATA204086A (de) Geraet zur verabreichung von medikamenten in pulverform
GB2173704B (en) Drug delivery device for programmed delivery of beneficial drug
ATA357683A (de) Vorrichtung zur verabreichung von medikamenten an patienten, einrichtung mit mehreren solchen vorrichtungen und traeger mit medikamentbehaeltern hiefuer
IT211830Z2 (it) Dispositivo di sicurezza perl'introduzione ed il prelievo di liquidi in e da flaconi di farmaci e simili.
AT384737B (de) Vorrichtung zur stroemungskonstanten abgabe fluessiger arzneimittel
DE3686897D1 (de) Arzneimittelabgabesystem mit kontrolliertem ph-wert.
FR2499859B1 (fr) Dispositif d'administration simultanee d'une substance pharmaceutique et d'un activateur d'absorption percutanee
ES296798Y (es) Organo de regulacion para medios gaseosos y liquidos.
DK390586D0 (da) Laegemiddelpartikler med konstant frigoerelseshastighed og umiddelbar absorption
DE3788729T2 (de) Vorrichtung und verabreichungssystem flüssiger materialien.
DE3688710D1 (de) Isolierung und pharmazeutische verwendung von hyaluronidase und diese enthaltende pharmazeutische und tieraerztliche praeparate.
ATE91912T1 (de) Vorrichtung zum schutz und zur verabreichung von fluessigkeitsempfindlichen arzneimitteln.
NO167953C (no) Beholder for lagring og utdeling av produkter.
DK246786A (da) Laegemiddel indeholdende vaevs-plasminogen-aktivator
EP0202159A3 (en) Drug delivery device which can be retained in the stomach for a controlled period of time
DK127887A (da) Interleukin-1beta-derivater og medikamenter indeholdende saadanne derivater
ATA262587A (de) Neue naphthalinderivate und sie enthaltende pharmazeutika
DE3678641D1 (de) Partikel mit konstanter wirkstofffreisetzung.
TR25479A (tr) Hasereleri ve kurtcuklari kovmaya mahsus maddeler
PT81805A (pt) Sistema transportador de contentores
DK162186A (da) Aminoketonderivater samt laegemidler indeholdende saadanne derivater
AT380230B (de) Duengemittel mit langzeitwirkung und programmierter naehrstoffabgabe
DE68921180T2 (de) Apparat für die Verabreichung von Medikamenten für die Veterinärmedizin.
IL75970A0 (en) Pharmaceutical preparations for the treatment of blood flow disturbances containing alkylenediamine derivatives and packages containing such preparations

Legal Events

Date Code Title Description
FG2A Definitive protection

Ref document number: 354973

Country of ref document: ES